$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How long can capmatinib (Touradida) prolong the survival of advanced patients?
2026-02-01 22:25:32
Check Details
Data on the effect of sotoracib (AMG 510) on prolonging the survival of patients with advanced disease
2026-02-01 22:25:32
Check Details
Study on the therapeutic efficacy and safety of adagrasib (Krazati) combined with pembrolizumab
2026-02-01 22:25:32
Check Details
Summary of overall treatment effects and clinical feedback of Larotrectinib
2026-02-01 22:25:32
Check Details
Blood and biochemical indicators that need to be monitored while taking Selinexol (Silvio)
2026-02-01 22:25:32
Check Details
Safety precautions when taking Vigabatrin to children
2026-02-01 22:25:32
Check Details
Where to buy Moboxetinib (Anvili) at the cheapest price and recommended through regular channels
2026-02-01 22:25:32
Check Details
Key points of home care and daily management during Tepotinib (Tuodekang) treatment
2026-02-01 22:25:32
Check Details
Evaluation of the clinical efficacy of regorafenib (Belvango) in the treatment of patients with colorectal cancer
2026-02-01 22:25:32
Check Details
Which drugs should not be taken with Pazopanib (Victor) and the potential risks
2026-02-01 22:25:32
Check Details
Liver function monitoring indicators and recommendations during Opicapone treatment
2026-02-01 22:25:32
Check Details
The effect of fenelidone (Keshenda) in reducing proteinuria and clinical feedback from patients
2026-02-01 22:25:32
Check Details
1
2
...
2029
2030
2031
2032
2033
2034
2035
...
10240
10241
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
2
Selumetinib for NF1-Related Plexiform Neurofibromas: Time to Response and Response Assessment
3
How to Take Tucatinib (Tukysa): Dosing Schedule, Combination Use & Missed Dose Guidance
4
Ganaxolone Common Side Effects: Somnolence, Sedation and Safety Notes
5
Baxdrostat: Efficacy and Safety of a Novel Aldosterone Synthase Inhibitor
6
Anamorelin (ADLUMIZ): GHS-R1a Agonist for Cancer Cachexia—Mechanism, Use, and Safety Boundaries
7
Vemurafenib Mechanism and Clinical Indications: BRAF V600E Mutant Melanoma and ECD Treatment
8
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
9
FDA Accelerated Approval of Voceryq: First Plasmid DNA Immunotherapy for Adult Recurrent Respiratory Papillomatosis
10
Ribociclib: Mechanism of Action and Approved Uses in Breast Cancer
11
Revumenib: Key Considerations Before and During Treatment
12
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control